僅用于工業(yè)應用或科學研究,不可用于人類或動物的臨床診斷或治療,非藥用.Azeliragon (TTP488) is an orally bioavailable inhibitor of the receptor for advanced glycation end products (RAGE) in development as a potential treatment to slow disease progression in patients with mild Alzheimer’s disease (AD).Azeliragon (TTP488) 是一種生物可利用的晚期糖基化終產(chǎn)物 (RAGE) 受體抑制劑,可緩解輕度阿爾茨海默病 (AD) 的發(fā)展